NCT07105891 (OVOfast) is a NA clinical trial of Thawing protocol in Oocyte Cryopreservation, sponsored by IRCCS San Raffaele.

Who is sponsoring NCT07105891?

NCT07105891 is sponsored by IRCCS San Raffaele.

What drugs are being tested in NCT07105891?

Interventions in NCT07105891: Thawing protocol, thawing protocol, thawing protocol.

What condition does NCT07105891 study?

NCT07105891 studies Oocyte Cryopreservation.

Is NCT07105891 still recruiting?

NCT07105891 is currently active, enrolled. Last updated 3 October 2025.

Last reviewed 2025-10-03 · How we verify

NCT07105891: OVOfast

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimization of Oocyte Warming Protocols

Active, enrolled NA Last updated 3 October 2025

What this trial tests

NA trial testing Thawing protocol in Oocyte Cryopreservation in 399 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

16 September 2025

Primary endpoint
15 October 2025

30 October 2025

Quick facts

Lead sponsor	IRCCS San Raffaele
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	399
Start date	16 September 2025
Primary completion	15 October 2025
Estimated completion	30 October 2025
Sites	1 location across Italy

Drugs / interventions tested

Thawing protocol
thawing protocol
thawing protocol

Conditions studied

Oocyte Cryopreservation — all drugs for Oocyte Cryopreservation →

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

Adults 18 to 40, female only, with Oocyte Cryopreservation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective study with a sibling design comparing new oocyte thawing protocols (rapid and ultra-rapid) with the traditional method

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oocyte Cryopreservation

Currently open trials in the same condition.

NCT06853418 — Paired Non-inferiority Study Comparing Overture Semi-automated Vitrification System ("DaVitri") to Standard Manual Proce · NA · recruiting

Other IRCCS San Raffaele trials

Trials by the same sponsor.

NCT07454759 — Acute Sarcopenia in Hospitalized Older Adults · not yet recruiting
NCT07456462 — Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance · NA · not yet recruiting
NCT07066878 — This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life B · not yet recruiting
NCT07526298 — Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Ap · not yet recruiting
NCT07426471 — Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections. · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07105891 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele
Last refreshed: 3 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07105891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing